Title : Biocomparison Study of Adult and Paediatric Dose Strengths of the Prostacyclin Receptor Agonist Selexipag.

Pub. Date : 2018 Feb

PMID : 28639216






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Biocomparison Study of Adult and Paediatric Dose Strengths of the Prostacyclin Receptor Agonist Selexipag. selexipag prostaglandin I2 receptor Homo sapiens
2 BACKGROUND AND OBJECTIVES: Selexipag is an oral, non-prostanoid, selective prostacyclin receptor agonist recently marketed for the treatment of pulmonary arterial hypertension (PAH) in adults. selexipag prostaglandin I2 receptor Homo sapiens